Korean court overturns KRX delisting rules

A Seoul court has suspended the delisting of KM Pharmaceutical, ruling that the Korea Exchange’s minimum market capitalization rules were unlawful and invalid. The Seoul Southern District Court on Friday granted the company’s request to suspend the effect of its Sept. 14 delisting decision until a final ruling in th…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.